Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-01-13 @ 1:20 PM
Study NCT ID:
NCT03792568
Status:
UNKNOWN
Last Update Posted:
2019-02-15
First Post:
2019-01-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.
Sponsor:
Shanghai Changzheng Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AICAM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None